Nalaganje...

Efficacy of Human-Simulated Epithelial Lining Fluid Exposure of Meropenem-Nacubactam Combination against Class A Serine β-Lactamase-Producing Enterobacteriaceae in the Neutropenic Murine Lung Infection Model

Nacubactam is a novel, broad-spectrum, β-lactamase inhibitor that is currently under development as combination therapy with meropenem. This study evaluated the efficacy of human-simulated epithelial lining fluid (ELF) exposures of meropenem, nacubactam, and the combination of meropenem and nacubact...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Antimicrob Agents Chemother
Main Authors: Asempa, Tomefa E., Motos, Ana, Abdelraouf, Kamilia, Bissantz, Caterina, Zampaloni, Claudia, Nicolau, David P.
Format: Artigo
Jezik:Inglês
Izdano: American Society for Microbiology 2019
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6437545/
https://ncbi.nlm.nih.gov/pubmed/30670411
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.02382-18
Oznake: Označite
Brez oznak, prvi označite!